Kissell bill endorsed by cancer organizations

CONCORD — The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010, introduced by U.S. Rep. Larry Kissell, has been endorsed by several national cancer organizations.

According to a Kissell press release, H.R. 4662 is designed to require Medicare to offer fair treatment coverage for Americans suffering from primary and secondary lymphedema.

Lymphedema, also known as lymphatic obstruction, is a condition of localized fluid retention and tissue swelling caused by a compromised lymphatic system. Many cancer patients suffer from this condition, the press release said.

“This is a terrible condition that affects thousands of Americans every day, and yet, many cannot get the treatment they need to improve their quality of life,” said Kissell, who represents the N.C. 8th District, in a press release. “After meeting many folks suffering from lymphedema, I believe this legislation will help dramatically improve their lives. I am grateful so many organizations dedicated to help those who fight cancer support the Lymphedema Diagnosis and Treatment Cost Saving Act.”

The treatment for lymphedema is known as complex decongestive therapy. Not all components of the treatment fall under the categories for which Medicare typically provides coverage, the press release said.

The Susan G. Komen for the Cure Advocacy Alliance, Living Beyond Breast Cancer and the Breast Cancer Network of Strength signed a joint letter of support, thanking Kissell on behalf of breast cancer survivors for introducing the bill.

Jennifer Luray, President, Komen Advocacy Alliance; Jean Sachs, CEO Living Beyond Breast Cancer; and Kay Wissman, Director of Government Relations for Breast Cancer Network of Strength, wrote, “Any woman who has breast cancer surgery and lymph nodes removed is at risk for developing lymphedema, and she remains at risk for the rest of her life.”

The Colon Cancer Alliance also has lent its support to the bill.

“It is vitally important that Medicare cover lymphedema treatment and treatment materials, including compression bandages and garments required for everyday care,” said Andrew Speigel, CEO of the Colon Cancer Alliance, according to the press release.

More than 39 organizations have endorsed H.R. 4662, including National Lymphedema Network, Lymphedema Awareness Foundation, Carolinas Rehabilitation and N.C. Comprehensive Cancer Program. Earlier this year, Lance Armstrong’s LIVESTRONG foundation also announced its endorsement.